VEGF‐null cells require PDGFR α signaling‐mediated stromal fibroblast recruitment for tumorigenesis
Open accessThe DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Watnick, R. S., Cheng, Y.-N., Rangarajan, A., Ince, T. A., & Weinberg, R. A. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00030-8 · Cited by 318
RetractedThe biology of VEGF and its receptors
Ferrara, N., Gerber, H.-P., & LeCouter, J. (2003) · Nature Medicine · doi:10.1038/nm0603-669 · Cited by 9,591 · cited 2×
“Sections 5mm thick were processed for in situ hybridization (Ferrara et al, 2003a).”
BackgroundMethodSelf-citationAngiogenesis in cancer and other diseases
Carmeliet, P., & Jain, R. K. (2000) · Nature · doi:10.1038/35025220 · Cited by 9,070 · cited 1×
“Angiogenesis, the formation of new blood vessels, is crucial for tumor growth, as tumor cells require oxygen and nutrients for proliferation and survival (Folkman, 1995; Carmeliet and Jain, 2000).”
BackgroundAngiogenesis in cancer, vascular, rheumatoid and other disease
Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0195-27 · Cited by 7,627
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., et al. (1996) · Nature · doi:10.1038/380435a0 · Cited by 4,117
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K. S., Powell-Braxton, L., Hillan, K. J., & Moore, M. W. (1996) · Nature · doi:10.1038/380439a0 · Cited by 3,628
Self-citationKim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S., & Ferrara, N. (1993) · Nature · doi:10.1038/362841a0 · Cited by 3,605
Self-citationBergers, G., Song, S., Meyer-Morse, N., Bergsland, E., & Hanahan, D. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17929 · Cited by 1,370
Molecular and biological properties of vascular endothelial growth factor
Ferrara, N. (1999) · Journal of Molecular Medicine · doi:10.1007/s001099900019 · Cited by 1,158
Self-citationFong, T. A. T., Shawver, L. K., Sun, L., Tang, C., App, H., Powell, T., Kim, Y. H., Schreck, R., Wang, X., Risau, W., et al. (1999) · PubMed · Cited by 1,109
Luttun, A., Tjwa, M., Moons, L., Wu, Y., Angelillo-Scherrer, A., Liao, F., Nagy, J. A., Hooper, A., Priller, J., De Klerck, B., et al. (2002) · Nature Medicine · doi:10.1038/nm731 · Cited by 1,068
Tumor Induction of VEGF Promoter Activity in Stromal Cells
Fukumura, D., Xavier, R., Sugiura, T., Chen, Y., Park, E.-C., Lu, N., Selig, M., Nielsen, G., Taksir, T., Jain, R. K., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81731-6 · Cited by 996
VEGF is required for growth and survival in neonatal mice
Gerber, H.-P., Hillan, K. J., Ryan, A. M., Kowalski, J., Keller, G.-A., Rangell, L., Wright, B. D., Radtke, F., Aguet, M., & Ferrara, N. (1999) · Development · doi:10.1242/dev.126.6.1149 · Cited by 915
Self-citationHiratsuka, S., Nakamura, K., Iwai, S., Murakami, M., Itoh, T., Kijima, H., Shipley, J. M., Senior, R. M., & Shibuya, M. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00153-8 · Cited by 910
Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall
Lindblom, P., Gerhardt, H., Liebner, S., Abramsson, A., Enge, M., Hellström, M., Bäckström, G., Fredriksson, S., Landegren, U., Nyström, H. C., et al. (2003) · Genes & Development · doi:10.1101/gad.266803 · Cited by 657
Hattori, K., Heissig, B., Wu, Y., Dias, S., Tejada, R., Ferris, B., Hicklin, D. J., Zhu, Z., Bohlen, P., Witte, L., et al. (2002) · Nature Medicine · doi:10.1038/nm740 · Cited by 633
Vascular endothelial growth factor is essential for corpus luteum angiogenesis
Ferrara, N., Chen, H., Davis-Smyth, T., Gerber, H.-P., Nguyen, T.-N., Peers, D., Chisholm, V., Hillan, K. J., & Schwall, R. H. (1998) · Nature Medicine · doi:10.1038/nm0398-336 · Cited by 624
Self-citationPDGF-C is a new protease-activated ligand for the PDGF α-receptor
Li, X., Pontén, A., Aase, K., Karlsson, L., Abramsson, A., Uutela, M., Bäckström, G., Hellström, M., Boström, H., Li, H., et al. (2000) · Nature Cell Biology · doi:10.1038/35010579 · Cited by 623
Roles of PDGF in animal development
Hoch, R. V., & Soriano, P. (2003) · Development · doi:10.1242/dev.00721 · Cited by 585
Abramsson, A., Lindblom, P., & Betsholtz, C. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18549 · Cited by 562
Lokker, N. A., Sullivan, C. M., Hollenbach, S. J., Israel, M. A., & Giese, N. A. (2002) · PubMed · Cited by 491
PDGF receptors as cancer drug targets
Pietras, K., Sjöblom, T., Rubin, K., Heldin, C.-H., & Östman, A. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00089-8 · Cited by 465
Hiratsuka, S., Maru, Y., Okada, A., Seiki, M., Noda, T., & Shibuya, M. (2001) · PubMed · Cited by 388
Darland, D. C., Massingham, L. J., Smith, S. R., Piek, E., Saint-Geniez, M., & D'Amore, P. A. (2003) · Developmental Biology · doi:10.1016/j.ydbio.2003.08.015 · Cited by 383
Inoue, M., Hager, J. H., Ferrara, N., Gerber, H.-P., & Hanahan, D. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00031-4 · Cited by 380
Self-citationVEGFR-1–Selective VEGF Homologue PlGF Is Arteriogenic: Evidence for a Monocyte-Mediated Mechanism
Pipp, F., Heil, M., Issbrücker, K., Ziegelhoeffer, T., Martin, S., van den Heuvel, J., Weich, H., Fernandez, B., Golomb, G., Carmeliet, P., et al. (2003) · Circulation Research · doi:10.1161/01.res.0000057997.77714.72 · Cited by 316
Platelet-derived Growth Factor C (PDGF-C), a Novel Growth Factor That Binds to PDGF α and β Receptor
Gilbertson, D. G., Duff, M. E., West, J. W., Kelly, J. D., Sheppard, P. O., Hofstrand, P. D., Gao, Z., Shoemaker, K., Bukowski, T. R., Moore, M., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101056200 · Cited by 292
Siegbahn, A., Hammacher, A., Westermark, B., & Heldin, C. H. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114519 · Cited by 255
Gerber, H., Kowalski, J., Sherman, D. A., Eberhard, D. A., & Ferrara, N. (2000) · PubMed · Cited by 251
Self-citationGrunstein, J., Roberts, W. G., Mathieu-Costello, O. A., Hanahan, D., & Johnson, R. S. (1999) · PubMed · Cited by 247
Self-citationForsberg, K., Valyi-Nagy, I., Heldin, C. H., Herlyn, M., & Westermark, B. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.2.393 · Cited by 238
Barberá‐Guillem, E., Nyhus, J. K., Wolford, C. C., Friece, C., & Sampsel, J. W. (2002) · PubMed · Cited by 233
Tumorigenic conversion of immortal human keratinocytes through stromal cell activation
Skobe, M., & Fusenig, N. E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.3.1050 · Cited by 233
New Members of the Platelet-Derived Growth Factor Family of Mitogens
Heldin, C.-H., Eriksson, U., & Östman, A. (2002) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2707 · Cited by 221
Tuxhorn, J. A., McAlhany, S. J., Yang, F., Dang, T. D., & Rowley, D. R. (2002) · PubMed · Cited by 216
Hlatky, L., Tsionou, C., Hahnfeldt, P., & Coleman, C. N. (1994) · PubMed · Cited by 212
Ferrara, N., Frantz, G., LeCouter, J., Dillard-Telm, L., Pham, T., Draksharapu, A., Giordano, T., & Peale, F. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64322-2 · Cited by 198
Self-citationComparison of Biological Properties and Transforming Potential of Human PDGF-A and PDGF-B Chains
Beckmann, M. P., Betsholtz, C., Heldin, C.-H., Westermark, B., Di Marco, E., Di Fiore, P. P., Robbins, K. C., & Aaronson, S. A. (1988) · Science · doi:10.1126/science.2842868 · Cited by 174
Kunz‐Schughart, L. A., & Knuechel, R. (2002) · PubMed · doi:10.14670/hh-17.599 · Cited by 161
Blaskovich, M. A., Lin, Q., Delarue, F. L., Sun, J., Park, H. S., Coppola, D., Hamilton, A. D., & Sebti, S. M. (2000) · Nature Biotechnology · doi:10.1038/80257 · Cited by 143
Tumor-associated fibroblasts (part II): Functional impact on tumor tissue.
Kunz‐Schughart, L. A., & Knuechel, R. (2002) · PubMed · doi:10.14670/hh-17.623 · Cited by 140
Coltrera, M. D., Wang, J., Porter, P. L., & Gown, A. M. (1995) · PubMed · Cited by 121
The role of the microenvironment and intercellular cross-talk in tumor angiogenesis
Ahmad, S. A., Jung, Y. D., Liu, W., Reinmuth, N., Parikh, A. A., Stoeltzing, O., Fan, F., & Ellis, L. M. (2002) · Seminars in Cancer Biology · doi:10.1006/scbi.2001.0418 · Cited by 119
Inhibition of vascular endothelial growth factor in the treatment of colorectal cancer
Fernando, N., & Hurwitz, H. I. (2003) · Seminars in Oncology · doi:10.1016/s0093-7754(03)70024-4 · Cited by 111
Ecstasy danger hits the headlines
Jones, R. (2002) · Nature reviews. Neuroscience · doi:10.1038/nrn974 · Cited by 103
Expression in lung carcinomas of platelet-derived growth factor and its receptors.
Kawai, T., Hiroi, S., & Torikata, C. (1997) · PubMed · Cited by 97
Kishimoto, J., Ehama, R., Ge, Y., Kobayashi, T., Nishiyama, T., Detmar, M. J., & Burgeson, R. E. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64522-1 · Cited by 86
Sulzbacher, I., Träxler, M., Mosberger, I., et al. (2000) · Modern Pathology · doi:10.1038/modpathol.3880109 · Cited by 84
Bhardwaj, B., Klassen, J., Cossette, N., et al. (1996) · PubMed · Cited by 81
Targeting Pdgf Receptors in Cancer Rationales and Proof of Concept Clinical Trials
George, D. J. (2003) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0081-0_12 · Cited by 77
Sundberg, C., Branting, M., Gerdin, B., & Rubin, K. (1997) · Europe PMC (PubMed Central) · Cited by 73
Viloria‐Petit, A., Miquerol, L., Yu, J. L., Gertsenstein, M., Sheehan, C., May, L., Henkin, J., Lobe, C., Nagy, A., Kerbel, R. S., et al. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg408 · Cited by 71
(2000) · doi:10.1002/1096-9896(2000)9999:9999 · Cited by 70
Ras regulation of vascular endothelial growth factor and angiogenesis
Rak, J. W., & Kerbel, R. S. (2001) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(01)33062-8 · Cited by 65
Pilch, H., Schlenger, K., Steiner, E., Brockerhoff, P., Knapstein, P., & Vaupel, P. W. (2001) · International Journal of Gynecological Cancer · doi:10.1046/j.1525-1438.2001.011002137.x · Cited by 62
Inhibition of vascular endothelial growth factor in the treatment of colorectal cancer
Fernando, N. H., & Hurwitz, H. I. (2003) · Seminars in Oncology · doi:10.1016/s0093-7754(03)00124-6 · Cited by 62
Dominant negative PDGF-C inhibits growth of Ewing family tumor cell lines
Zwerner, J. P., & May, W. A. (2002) · Oncogene · doi:10.1038/sj.onc.1205486 · Cited by 56
Shi, Y., & Ferrara, N. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9966 · Cited by 39
Self-citationCella, D. F. (2003) · Seminars in Oncology · doi:10.1053/sonc.2003.50031 · Cited by 29
Hu, M., Pollock, R. E., & Nicolson, G. L. (1997) · PubMed · Cited by 18
Betsholtz, C., Nistér, M., Rorsman, F., Heldin, C., & Westermark, B. (1989) · Molecular and Chemical Neuropathology · doi:10.1007/bf02969484 · Cited by 17
Cook, J. R., Wang, D., & Chen, J. (1993) · Life Sciences · doi:10.1016/0024-3205(93)90502-t · Cited by 4
Cited by
Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis
Hicklin, D. J., & Ellis, L. M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.081 · Cited by 3,007
Angiogenesis as a therapeutic target
Ferrara, N., & Kerbel, R. S. (2005) · Nature · doi:10.1038/nature04483 · Cited by 2,653
Self-citationRole of platelet-derived growth factors in physiology and medicine
Andrae, J., Gallini, R., & Betsholtz, C. (2008) · Genes & Development · doi:10.1101/gad.1653708 · Cited by 2,438
Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy
Ferrara, N., Hillan, K. J., & Novotny, W. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.05.132 · Cited by 977
Self-citationBarry-Hamilton, V., Spangler, R., Marshall, D., McCauley, S., Rodriguez, H. M., Oyasu, M., Mikels, A., Vaysberg, M., Ghermazien, H., Wai, C., et al. (2010) · Nature Medicine · doi:10.1038/nm.2208 · Cited by 870
Metadata
- Authors
- Dong, J., Grunstein, J., Tejada, M., Peale, F., Frantz, G., Liang, W., Bai, W., Yu, L., Kowalski, J., Liang, X., Fuh, G., Gerber, H., & Ferrara, N.
- Venue
- The EMBO Journal
- Published
- 2004-07-01
- Volume
- 23
- Issue
- 14
- Pages
- 2800-2810
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- OpenAlex
- W2116991471
- Cited by
- 295
- References
- 63
- FWCI
- 6.01
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.